181 related articles for article (PubMed ID: 8812223)
1. Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling.
Williams RJ; Vinegar A; McDougal JN; Jarabek AM; Fisher JW
Fundam Appl Toxicol; 1996 Mar; 30(1):55-66. PubMed ID: 8812223
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat.
Vinegar A; Williams RJ; Fisher JW; McDougal JN
Toxicol Appl Pharmacol; 1994 Nov; 129(1):103-13. PubMed ID: 7974482
[TBL] [Abstract][Full Text] [Related]
3. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation.
Harris JW; Jones JP; Martin JL; LaRosa AC; Olson MJ; Pohl LR; Anders MW
Chem Res Toxicol; 1992; 5(5):720-5. PubMed ID: 1446014
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
Urban G; Speerschneider P; Dekant W
Chem Res Toxicol; 1994; 7(2):170-6. PubMed ID: 8199305
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights aid the search for CFC substitutes: risk assessment of HCFC-123 as an example.
Jarabek AM; Fisher JW; Rubenstein R; Lipscomb JC; Williams RJ; Vinegar A; McDougal JN
Risk Anal; 1994 Jun; 14(3):231-50. PubMed ID: 8029495
[TBL] [Abstract][Full Text] [Related]
6. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
Huwyler J; Aeschlimann D; Christen U; Gut J
Eur J Biochem; 1992 Jul; 207(1):229-38. PubMed ID: 1628651
[TBL] [Abstract][Full Text] [Related]
7. Trifluoroacetylated proteins in liver and plasma of guinea pigs treated with HCFC-123 and halothane.
Bortolato S; Zanovello A; Rugge M; Brotto M; Marini S; Gervasi PG; Manno M
Toxicol Lett; 2003 Sep; 144(1):35-47. PubMed ID: 12919722
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based pharmacokinetic analysis of the concentration-dependent metabolism of halothane.
Loizou GD; Tran CL; Anders MW
Xenobiotica; 1997 Jan; 27(1):87-99. PubMed ID: 9041681
[TBL] [Abstract][Full Text] [Related]
9. Exposure to the chlorofluorocarbon substitute 2,2-dichloro-1,1,1- trifluoroethane and the anesthetic agent halothane is associated with transient protein adduct formation in the heart.
Huwyler J; Gut J
Biochem Biophys Res Commun; 1992 May; 184(3):1344-9. PubMed ID: 1590796
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and pharmacokinetics of selected halon replacement candidates.
Dodd DE; Brashear WT; Vinegar A
Toxicol Lett; 1993 May; 68(1-2):37-47. PubMed ID: 8516773
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs.
Hoet P; Buchet JP; Sempoux C; Haufroid V; Rahier J; Lison D
Arch Toxicol; 2002 Dec; 76(12):707-14. PubMed ID: 12451447
[TBL] [Abstract][Full Text] [Related]
12. Effects of HCFC-123 exposure to maternal and infant rhesus monkeys on hepatic biochemistry, lactational parameters and postnatal growth.
Cappon GD; Keller DA; Brock WJ; Slauter RW; Hurtt ME
Drug Chem Toxicol; 2002 Nov; 25(4):481-96. PubMed ID: 12378954
[TBL] [Abstract][Full Text] [Related]
13. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
Loizou GD; Urban G; Dekant W; Anders MW
Drug Metab Dispos; 1994; 22(4):511-7. PubMed ID: 7956723
[TBL] [Abstract][Full Text] [Related]
14. Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.
Harris JW; Pohl LR; Martin JL; Anders MW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1407-10. PubMed ID: 1996342
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 1-fluoro-1,1,2-trichloroethane, 1,2-dichloro-1,1-difluoroethane, and 1,1,1-trifluoro-2-chloroethane.
Yin H; Jones JP; Anders MW
Chem Res Toxicol; 1995 Mar; 8(2):262-8. PubMed ID: 7766810
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats.
Urban G; Dekant W
Xenobiotica; 1994 Sep; 24(9):881-92. PubMed ID: 7810170
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the hydrochlorofluorocarbon 1,2-dichloro-1,1-difluoroethane.
Harris JW; Anders MW
Chem Res Toxicol; 1991; 4(2):180-6. PubMed ID: 1782346
[TBL] [Abstract][Full Text] [Related]
18. Reductive activation of HCFC-123 by methaemalbumin.
Zanovello A; Ferrara R; Manno M
Toxicol Lett; 2003 Sep; 144(1):127-36. PubMed ID: 12919730
[TBL] [Abstract][Full Text] [Related]
19. Investigations on the liver toxicity of a blend of HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane) and HCFC-124 (2-chloro-1,1,1,2-tetrafluoroethane) in guinea-pigs.
Hoet P; Buchet JP; Sempoux C; Nomiyama T; Rahier J; Lison D
Arch Toxicol; 2001 Jul; 75(5):274-83. PubMed ID: 11548120
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
Ferrara R; Tolando R; King LJ; Manno M
Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
